Evidence map›Paper›PMID 39726502›Full record

ArticleCureus2024

Bitter Taste Sensitivity, Food Cravings, and Risk of Chronic Disease: A Cross-Sectional Study.

Tony Jehi, Hildemar Dos Santos, Gigi Kwok-Hinsley

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tony JehiSchool of Public Health and Health Sciences, California State University, Dominguez Hills (CSUDH), Carson, USA.
Hildemar Dos SantosPreventive Care, School of Public Health, Loma Linda University, Loma Linda, USA.
Gigi Kwok-HinsleySchool of Public Health, Loma Linda University, Loma Linda, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionVariation in common taste receptor type 2 member 38 (TAS2R38) haplotypes is associated with bitter taste sensitivity, but there is not much or inconsistent evidence on association with food cravings and with chronic disease risk factors. We have conducted a cross-sectional study to assess whether genetically defined taster groups would differ in their sensitivity to bitter-tasting compounds, cravings for various food groups, and risk of chronic disease risk factors.  Methodology: A total of 116 non-diabetic individuals were recruited from the Loma Linda University (LLU) campus. Various measures were carried out to examine genetic variations, bitter sensitivity, anthropometrics, food cravings, and participant demographics. Taster status was determined based on TAS2R38 haplotypes, classifying participants as super-tasters, tasters, or non-tasters. Analysis of Covariance (ANCOVA) models were used to examine differences among the three TAS2R38 genetic groups in bitter taste sensitivity, food cravings, body mass index (BMI), non-fasting blood glucose, and family history of type 2 diabetes (T2D).

resultsA significant difference in sensitivity to the bitter taste compounds thiourea and phenylthiocarbamide (PTC) was observed among the three TAS2R38 genetic groups (

conclusionsSuper-tasters had the lowest taste sensitivity for bitter compounds and the highest cravings for bitter foods, which suggests that they might be more likely to consume bitter foods. Examining the genetic differences in taste preferences and sensitivities may pave the way for effective and individualized dietary plans and intervention strategies targeting chronic disease prevention, treatment, and management.

Indexed as

bitter tastechronic disease riskfood cravingstas2r38taste sensitivity

Identifiers

PMID39726502
PMCPMC11670823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.